Molecular Oncology (Aug 2011)

p53: Guardian of ploidy

  • Yael Aylon,
  • Moshe Oren

DOI
https://doi.org/10.1016/j.molonc.2011.07.007
Journal volume & issue
Vol. 5, no. 4
pp. 315 – 323

Abstract

Read online

Abstract Aneuploidy, often preceded by tetraploidy, is one of the hallmarks of solid tumors. Indeed, both aneuploidy and tetraploidy are oncogenic occurrences that are sufficient to drive neoplastic transformation and cancer progression. True to form, the tumor suppressor p53 obstructs propagation of these dangerous chromosomal events by either instigating irreversible cell cycle arrest or apoptosis. The tumor suppressor Lats2, along with other tumor inhibitory proteins such as BRCA1/2 and BubR1, are central to p53‐dependent elimination of tetraploid cells. Not surprisingly, these proteins are frequently inactivated or downregulated in tumors, synergizing with p53 inactivation to establish an atmosphere of “tolerance” for a non‐diploid state.

Keywords